Company / selected milestones

A platform built over time.

SoftMining has evolved through scientific tools, international programmes, collaborative projects and physical experimentation. This is a selected company timeline—not a complete news archive.

MethodsProjectsInternational growthPlatform integration
Editorial visual timeline of a scientific startup evolving into an integrated discovery platform
From individual methods to a connected discovery systemScientific tools, international presence and the physical loop converged into ADAPT and SYNTHEX.

2026 → 2019 / Reverse chronology

Selected milestones in science, projects and growth

The historical site contains a much longer sequence of product announcements, conferences and project updates. Here we keep only milestones that help explain how the present company and platform emerged.

2026

DeepSage online

DeepSage goes online as SoftMining’s evidence-intelligence layer, converting graph-linked scientific literature into structured, citation-backed reports while preserving dominant and minority evidence as distinct signals.

2026

Partnership with Biovista

SoftMining and Biovista strengthen their collaboration around evidence-backed biomedical knowledge graphs and drug-repurposing workflows, combining SoftMining computational methods with Biovista’s Vizit environment and the experience developed through NEWROAD.

2025

Repo4EU community

SoftMining joined the Repo4EU community focused on drug repurposing and network medicine.

2025

ADAPT online

ADAPT was announced online as SoftMining's integrated platform connecting AI-driven discovery with synthesis and testing workflows.

2024

SWITCH Singapore

SoftMining took part in Singapore Week of Innovation and Technology, extending its international business-development activity.

2023

Italian eHealth recognition

SoftMining was included among 15 Italian startups to follow in the eHealth sector.

2023

Zurich presence

SoftMining GmbH was incorporated in Zurich, Switzerland.

2022

Singapore presence

SoftMining Pte. Ltd. was incorporated in Singapore.

2022

NEWROAD begins

SoftMining joined the EU-funded NEWROAD project on systematic drug repurposing in oncology.

2022

MIND / Eurostars

The MIND project received Eurostars support for work focused on molecules for neurological diseases.

2021

IRCAI Global Top 100

SoftMining's semantic-analysis work entered the IRCAI Global Top 100 list.

2019

International innovation network

SoftMining participated in the EIT Health InnoStars Headstart programme and other early international startup initiatives, establishing an initial international footprint.

What changed

The trajectory is from tools to a connected discovery system.

Individual computational methods, international collaborations and experimental capabilities progressively converged into ADAPT orchestration and the SYNTHEX physical loop.

Phase 01

Method development

Early work was centred on scientific methods, semantic analysis and computational components.

Phase 02

Projects and validation

Collaborative projects and translational programmes helped turn isolated tools into structured workflows.

Phase 03

Integrated platform

The result is a system where evidence, modelling, synthesis and validation remain connected.

Next phase

The story is not the archive. It is what the system can do now.

The timeline matters only because it explains the current platform and the next wave of programmes and collaborations.